{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T13:48:59Z","timestamp":1648907339659},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,9,26]],"date-time":"2014-09-26T00:00:00Z","timestamp":1411689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s00432-014-1834-9","type":"journal-article","created":{"date-parts":[[2014,9,25]],"date-time":"2014-09-25T06:56:33Z","timestamp":1411628193000},"page":"555-562","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Adjuvant treatment decisions for patients with endometrial cancer in Germany: results of the nationwide AGO pattern of care studies from the years 2013, 2009 and 2006"],"prefix":"10.1007","volume":"141","author":[{"given":"Marco Johannes","family":"Battista","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Rieks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Sicking","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Albrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Eichbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz","family":"Koelbl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Mallmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,26]]},"reference":[{"key":"1834_CR1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/gyno.1996.0022","volume":"60","author":"I Ackerman","year":"1996","unstructured":"Ackerman I, Malone S, Thomas M, Franssen E, Balogh J, Dembo A (1996) Endometrial carcinoma-relative effectiveness of adjuvant irradiation vs therapy reserved for relapse. Gynecol Oncol 60:177\u2013183","journal-title":"Gynecol Oncol"},{"key":"1834_CR2","unstructured":"AGO (2006) Leitlinie Endometriumkarzinom. http:\/\/www.ago-online.de\/_download\/unprotected\/LeitlinieEndometriumkarzinomEndversion.pdf. Accessed 5 May 2011"},{"key":"1834_CR3","unstructured":"AGO (2013) Empfehlungen f\u00fcr die Diagnostik und Therapie des Endometriumkarzinoms. http:\/\/www.ago-online.de\/fileadmin\/downloads\/leitlinien\/uterus\/empfehlungen_diagnostik_therapie_EC.pdf. Accessed 21 Mar 2014"},{"key":"1834_CR4","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.ajog.2004.12.032","volume":"192","author":"T Akram","year":"2005","unstructured":"Akram T, Maseelall P, Fanning J (2005) Carboplatin and paclitaxel for the treatment of advanced or recurrent endometrial cancer. Am J Obstet Gynecol 192:1365\u20131367","journal-title":"Am J Obstet Gynecol"},{"key":"1834_CR5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/IGC.0b013e3182781a6c","volume":"23","author":"MJ Battista","year":"2013","unstructured":"Battista MJ, Steiner E, Rieks N, Steetskamp J, Seeger A, Sicking I et al (2013) Nationwide analysis on surgical staging procedures and systemic treatment for patients with endometrial cancer in Germany. Int J Gynecol Cancer 23:105\u2013112","journal-title":"Int J Gynecol Cancer"},{"key":"1834_CR6","author":"MJ Battista","year":"2014","unstructured":"Battista MJ, Schmidt M, Rieks N, Steetskamp J, Sicking I, Lebrecht A et al (2014) Nationwide analysis on surgical procedures for patients with endometrial cancer in Germany: results of the AGO pattern of care studies from the years 2013, 2009, and 2006. J Cancer Res Clin Oncol. doi: 10.1007\/s00432-014-1755-7","journal-title":"J Cancer Res Clin Oncol"},{"key":"1834_CR7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0140-6736(08)61767-5","volume":"373","author":"P Blake","year":"2009","unstructured":"Blake P, Swart AM, Orton J, Kitchener H, Whelan T, Lukka H et al (2009) Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis. Lancet 373:137\u2013146","journal-title":"Lancet"},{"key":"1834_CR8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijgo.2009.02.010","volume":"105","author":"W Creasman","year":"2009","unstructured":"Creasman W (2009) Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet 105:109","journal-title":"Int J Gynaecol Obstet"},{"key":"1834_CR9","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","volume":"355","author":"CL Creutzberg","year":"2000","unstructured":"Creutzberg CL, Van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, W\u00e1rl\u00e1m-Rodenhuis CC et al (2000) Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post operative radiation therapy in endometrial Carcinoma. Lancet 355:1404\u20131411","journal-title":"Lancet"},{"key":"1834_CR10","first-page":"73","volume-title":"Leitlinien zum Zervixkarzinom, zum Endometriumkarzinom und zu den Trophoblasttumoren","author":"G Emons","year":"2008","unstructured":"Emons G, Kimmig R (2008) Interdisziplin\u00e4re S2\u00a0k-Leitlinie f\u00fcr die Diagnostik und Therapie des Endometriumkarzinoms. In: Horn LC, Beckmann MW (eds) Leitlinien zum Zervixkarzinom, zum Endometriumkarzinom und zu den Trophoblasttumoren. Zuckschwerdt, M\u00fcnchen, pp 73\u2013126"},{"key":"1834_CR11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0167-8140(02)00212-8","volume":"65","author":"A Hasbini","year":"2002","unstructured":"Hasbini A, Haie-Meder C, Morice P, Chirat E, Duvillard P, Lhomm\u00e9 C et al (2002) Outcome after salvage radiotherapy (brachytherapy\u00a0\u00b1\u00a0external) in patients with a vaginal recurrence from endometrial carcinomas. Radiother Oncol 65:23\u201328","journal-title":"Radiother Oncol"},{"key":"1834_CR12","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.ejca.2010.06.002","volume":"46","author":"T Hogberg","year":"2010","unstructured":"Hogberg T, Signorelli M, De Oliveira CF, Fossati R, Lissoni AA, Sorbe B et al (2010) Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer\u2014results from two randomised studies. Eur J Cancer 46:2422\u20132431","journal-title":"Eur J Cancer"},{"key":"1834_CR13","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1200\/JCO.2001.19.20.4048","volume":"19","author":"PJ Hoskins","year":"2001","unstructured":"Hoskins PJ, Swenerton KD, Pike JA, Wong F, Lim P, Acquino-Parsons C et al (2001) Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: a phase II study. J Clin Oncol 19:4048\u20134053","journal-title":"J Clin Oncol"},{"key":"1834_CR14","author":"N Johnson","year":"2011","unstructured":"Johnson N, Bryant A, Miles T, Hogberg T, Cornes P (2011) Adjuvant chemotherapy for endometrial cancer after hysterectomy. Cochrane Database Syst Rev. doi: 10.1002\/14651858.CD003175.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"1834_CR15","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","volume":"92","author":"HM Keys","year":"2004","unstructured":"Keys HM, Roberts JA, Brunetto VL, Zaino RJ, Spirtos NM, Bloss JD et al (2004) A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a gynecologic oncology group study. Gynecol Oncol 92:744\u2013751","journal-title":"Gynecol Oncol"},{"key":"1834_CR16","unstructured":"Koh W-J, Greer BE, Abu-Rustum NR (2014) Uterine neoplasms NCCN clinical practice guidelines in oncology. www.nccn.org . Accessed 4 April 2014"},{"key":"1834_CR17","author":"A Kong","year":"2012","unstructured":"Kong A, Johnson N, Kitchener HC, Lawrie TA (2012) Adjuvant radiotherapy for stage I endometrial cancer. Cochrane Database Syst Rev. doi: 10.1002\/14651858.CD003916.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"1834_CR18","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ygyno.2008.03.020","volume":"110","author":"T Kuoppala","year":"2008","unstructured":"Kuoppala T, M\u00e4enp\u00e4\u00e4 J, Tomas E, Puistola U, Salmi T, Grenman S et al (2008) Surgically staged high-risk endometrial cancer: randomized study of adjuvant radiotherapy alone vs sequential chemo-radiotherapy. Gynecol Oncol 110:190\u2013195","journal-title":"Gynecol Oncol"},{"key":"1834_CR19","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1002\/cncr.22997","volume":"110","author":"CM Lee","year":"2007","unstructured":"Lee CM, Szabo A, Shrieve DC, Macdonald OK, Tward JD, Skidmore TB et al (2007) Descriptive nomograms of adjuvant radiotherapy use and patterns of care analysis for stage I and II endometrial adenocarcinoma: a surveillance, epidemiology, and end results population study. Cancer 110:2092\u20132100","journal-title":"Cancer"},{"key":"1834_CR20","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/sj.bjc.6603279","volume":"95","author":"R Maggi","year":"2006","unstructured":"Maggi R, Lissoni A, Spina F, Melpignano M, Zola P, Favalli G et al (2006) Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. Br J Cancer 95:266\u2013271","journal-title":"Br J Cancer"},{"key":"1834_CR21","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/0090-8258(90)90166-I","volume":"36","author":"CP Morrow","year":"1990","unstructured":"Morrow CP, Bundy BN, Homesley HD, Creasman WT, Hornback N, Kurman R et al (1990) Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: a gynecologic oncology group study. Gynecol Oncol 36:166\u2013171","journal-title":"Gynecol Oncol"},{"key":"1834_CR22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ygyno.2006.11.003","volume":"105","author":"RW Naumann","year":"2007","unstructured":"Naumann RW, Coleman RL (2007) The use of adjuvant radiation therapy in early endometrial cancer by members of the society of gynecologic oncologists in 2005. Gynecol Oncol 105:7\u201312","journal-title":"Gynecol Oncol"},{"key":"1834_CR23","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1006\/gyno.1999.5548","volume":"75","author":"RW Naumann","year":"1999","unstructured":"Naumann RW, Higgins RV, Hall JB (1999) The use of adjuvant radiation therapy by members of the society of gynecologic oncologists. Gynecol Oncol 75:4\u20139","journal-title":"Gynecol Oncol"},{"key":"1834_CR24","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1200\/JCO.2008.20.2424","volume":"27","author":"RA Nout","year":"2009","unstructured":"Nout RA, Putter H, J\u00fcrgenliemk-Schulz IM, Jobsen JJ, Lutgens LC, Van der Steen-Banasik EM et al (2009) Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial. J Clin Oncol 27:3547\u20133556","journal-title":"J Clin Oncol"},{"key":"1834_CR25","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","volume":"375","author":"RA Nout","year":"2010","unstructured":"Nout RA, Smit VT, Putter H, J\u00fcrgenliemk-Schulz IM, Jobsen JJ, Lutgens LC et al (2010) Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet 375:816\u2013823","journal-title":"Lancet"},{"key":"1834_CR26","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1200\/JCO.2004.00.7617","volume":"24","author":"ME Randall","year":"2006","unstructured":"Randall ME, Filiaci VL, Muss H, Spirtos NM, Mannel RS, Fowler J et al (2006) Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a gynecologic oncology group study. J Clin Oncol 24:36\u201344","journal-title":"J Clin Oncol"},{"key":"1834_CR27","unstructured":"Robert Koch Institut (2010) Geb\u00e4rmutterk\u00f6rper. Krebs in Deutschland. http:\/\/www.rki.de\/Krebs\/DE\/Content\/Publikationen\/Krebs_in_Deutschland\/kid_2013\/kid_2013_c54-55_gebaermutterkoerper.pdf;jsessionid=D687D7570E564374CAB3C53CCABF8F0E.2_cid390?__blob=publicationFile . Accessed 22 Feb 2014"},{"key":"1834_CR28","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1525-1438.2007.01094.x","volume":"18","author":"B Sorbe","year":"2008","unstructured":"Sorbe B, Andersson H, Boman K, Rosenberg P, Kalling M (2008) Treatment of primary advanced and recurrent endometrial carcinoma with a combination of carboplatin and paclitaxel-long-term follow-up. Int J Gynecol Cancer 18:803\u2013808","journal-title":"Int J Gynecol Cancer"},{"key":"1834_CR29","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/IGC.0b013e3181a6c9df","volume":"19","author":"B Sorbe","year":"2009","unstructured":"Sorbe B, Nordstr\u00f6m B, M\u00e4enp\u00e4\u00e4 J, Kuhelj J, Kuhelj D, Okkan S et al (2009) Intravaginal brachytherapy in FIGO stage I low-risk endometrial cancer: a controlled randomized study. Int J Gynecol Cancer 19:837\u2013838","journal-title":"Int J Gynecol Cancer"},{"key":"1834_CR30","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.ijrobp.2011.04.014","volume":"82","author":"B Sorbe","year":"2012","unstructured":"Sorbe B, Horvath G, Andersson H, Boman K, Lundgren C, Pettersson B (2012) External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma\u2014a prospective randomized study. Int J Radiat Oncol Biol Phys 82:1249\u20131255","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1834_CR31","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ygyno.2007.09.029","volume":"108","author":"N Susumu","year":"2008","unstructured":"Susumu N, Sagae S, Udagawa Y, Niwa K, Kuramoto H, Satoh S et al (2008) Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group Study. Gynecol Oncol 108:226\u2013233","journal-title":"Gynecol Oncol"},{"key":"1834_CR32","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ygyno.2009.08.016","volume":"115","author":"Y Watanabe","year":"2009","unstructured":"Watanabe Y, Kitagawa R, Aoki D, Takeuchi S, Sagae S, Sakuragi N et al (2009) Practice pattern for postoperative management of endometrial cancer in Japan: a survey of the Japanese gynecologic oncology group. Gynecol Oncol 115:456\u2013459","journal-title":"Gynecol Oncol"},{"key":"1834_CR33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ygyno.2011.02.040","volume":"122","author":"JD Wright","year":"2011","unstructured":"Wright JD, Lewin SN, Barrena Medel NI, Sun X, Burke WM, Deutsch I et al (2011) Endometrial cancer in the oldest old: tumor characteristics, patterns of care, and outcome. Gynecol Oncol 122:69\u201374","journal-title":"Gynecol Oncol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-014-1834-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-014-1834-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-014-1834-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T07:07:50Z","timestamp":1565852870000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-014-1834-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,26]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["1834"],"URL":"https:\/\/doi.org\/10.1007\/s00432-014-1834-9","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,26]]}}}